Brief: TOT Biopharm International Posts FY Net Income Of RMB34.757 Mln
11/03/2025 14:53
March 11 (Reuters) - TOT BIOPHARM International Co Ltd 1875.HK: FY NET INCOME RMB 34.757 MILLION FY CASH FLOW FROM OPERATING ACTIVITIES RMB 116.403 MILLION FY REVENUE RMB 1,000 MILLION Further company coverage: 1875.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioDlink International
See all newsCorrected: China's BioDlink International HY revenue falls (September 29)
Brief: Biodlink International To Deliver Ten Batches Of Monoclonal Antibody Intermediates To Wuxi Biologics
Brief: Biodlink International Says Shan Fu Resigns As Executive Director And Chairperson
Brief: BioDlink International Says WuXi XDC Cayman To Make Conditional Cash Offer For All Co Shares
Brief: HKEX Says Trading In Shares Of Biodlink International Will Be Halted At Dec 29